Description
SR144528 is a selective CB2 antagonist. It is used to study the role of cannabinoid receptor 2 in immunology, neuroscience and cancer. Recent research shows SR144528 to reduce immunoglobulin human SKW 6.4 cells.
Product Unit Size | Cost | Quantity | Stock |
---|
SR144528 is a selective CB2 antagonist. It is used to study the role of cannabinoid receptor 2 in immunology, neuroscience and cancer. Recent research shows SR144528 to reduce immunoglobulin human SKW 6.4 cells.
Cas No. | 192703-06-3 |
---|---|
Purity | ≥98% |
Formula | C29H34ClIN3O |
Formula Wt. | 476.06 |
Chemical Name | 5-(4-chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1R,3S,4S)-2,2,4-trimethyl-3-bicyclo[2.2.1]heptanyl]pyrazole-3-carboxamide |
IUPAC Name | 5-(4-Chloro-3-methylphenyl)-1-[(4-methylphenyl)methyl]-N-[(1S,2S,4R)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-yl]-1H-pyrazole-3-carboxamide |
Solubility | Soluble in ethanol (~20 mg/ml), DMSO (~20 mg/ml), DMF (~20 mg/ml), and 1: 1 ethanol: PBS (pH 7.2) (~0.5 mg/ml). |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Feng R, Milcarek CA, Xie XQ. Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion. BMC Pharmacol Toxicol. 2014 Jun 9;15:30. PMID: 24913620.
Krylatov AV, Maslov LN, Lasukova OV and Pertwee RG. Cannabinoid receptor antagonists SR141716 and SR144528 exhibit properties of partial agonists in experiments on isolated perfused rat heart. Bull Exp Biol Med. 2005 May;139(5):558-61. PMID: 16224548.
Methylxanthine; PDE inhibitor, A1/2 adenosine a...
MEK1/2 and ERK inhibitor.
Fluoroquinolone; topoisomerase IV and bacterial...
Insecticide; α-adrenergic agonist, MAO inhibit...
Selective inhibitor of LRRK2.
Endogenous peptide hormone fragment, involved i...
α1-adrenergic antagonist.
Synthetic peptide; FPRL1 agonist.
Coumarin; VKORC1 inhibitor.
ALK and Ros1 inhibitor, Trk antagonist.
Taxane synthesis intermediate.
NSAID; COX-1/2 inhibitor.
σ1 antagonist.
M4 mAChR agonist, 5-HT1A partial agonist, M1/2/...
AMPK activator, L-type Ca2+ channel and NMDA, h...
MEK inhibitor.
Building block
Inhibitor of Bruton’s tyrosine kinase (BTK).<...
Coumarin; VKORC1 inhibitor.
Non-opioid analgesic.